Eli Lilly (NYSE: LLY) and Novo Nordisk (NYSE: NVO), the kings of the titanic weight-loss drugs market, might have a problem ...
Excitement is building around a new weight loss drug, CagriSema, which is expected to surpass the effects of popular drugs ...
The Motley Fool on MSN6h
Is Viking Therapeutics a Buy on the Dip?You'll probably recognize their names after seeing them in the news or across social media: Ozempic and Wegovy (made by Novo ...
In good news for those averse to injections, GLP-1 agonist medication is a step closer to being offered in oral pill form, ...
Since its approval in mid-March of 2024, sales of Rezdiffra are increasing expediciously, reaching $62.2 million in Q3, the ...
A 58-year-old nurse from Scotland has died after taking two doses of weight-loss drug tirzepatide, also known as Mounjaro or ...
In corporate news, Novo Nordisk A/S (NOVOB.C.DX) surged over +7% after the pharmaceutical giant reported better-than-expected Q3 sales of its popular Wegovy weight-loss drug and narrowed its full-year ...
CENTRAL GOVERNMENT FUNDS: Social welfare would account for the largest portion of the NT$3.33 trillion budget, followed by spending on education, tech and culture ...
Former All Blacks Steven Bates and Angus Ta’avao have praised New Zealand’s stunning 23-13 win over Ireland. Whether you’re a fan of the All Blacks, a follower of the women’s game or someone who ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback